1. Home
  2. RLMD vs STRM Comparison

RLMD vs STRM Comparison

Compare RLMD & STRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • STRM
  • Stock Information
  • Founded
  • RLMD 2004
  • STRM 1989
  • Country
  • RLMD United States
  • STRM United States
  • Employees
  • RLMD N/A
  • STRM N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • STRM EDP Services
  • Sector
  • RLMD Health Care
  • STRM Technology
  • Exchange
  • RLMD Nasdaq
  • STRM Nasdaq
  • Market Cap
  • RLMD 22.0M
  • STRM 22.3M
  • IPO Year
  • RLMD N/A
  • STRM 1996
  • Fundamental
  • Price
  • RLMD $0.67
  • STRM $5.18
  • Analyst Decision
  • RLMD Buy
  • STRM
  • Analyst Count
  • RLMD 3
  • STRM 0
  • Target Price
  • RLMD $5.00
  • STRM N/A
  • AVG Volume (30 Days)
  • RLMD 478.7K
  • STRM 202.4K
  • Earning Date
  • RLMD 08-06-2025
  • STRM 06-16-2025
  • Dividend Yield
  • RLMD N/A
  • STRM N/A
  • EPS Growth
  • RLMD N/A
  • STRM N/A
  • EPS
  • RLMD N/A
  • STRM N/A
  • Revenue
  • RLMD N/A
  • STRM $18,381,000.00
  • Revenue This Year
  • RLMD N/A
  • STRM $18.64
  • Revenue Next Year
  • RLMD N/A
  • STRM N/A
  • P/E Ratio
  • RLMD N/A
  • STRM N/A
  • Revenue Growth
  • RLMD N/A
  • STRM N/A
  • 52 Week Low
  • RLMD $0.24
  • STRM $1.82
  • 52 Week High
  • RLMD $4.47
  • STRM $9.45
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 52.84
  • STRM 80.01
  • Support Level
  • RLMD $0.67
  • STRM $5.14
  • Resistance Level
  • RLMD $0.72
  • STRM $5.24
  • Average True Range (ATR)
  • RLMD 0.08
  • STRM 0.03
  • MACD
  • RLMD -0.03
  • STRM -0.08
  • Stochastic Oscillator
  • RLMD 40.29
  • STRM 30.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About STRM Streamline Health Solutions Inc.

Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.

Share on Social Networks: